NASDAQ: LUCD
Lucid Diagnostics Inc Stock Ownership - Who owns Lucid Diagnostics?

Insider buying vs selling

Have Lucid Diagnostics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when LUCD insiders and whales buy or sell their stock.

LUCD Shareholders

What type of owners hold Lucid Diagnostics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Pavmed Inc34.49%31,302,444$37.88MInsider
Lishan Aklog1.62%1,466,627$1.77MInsider
Dennis M. McGrath1.48%1,343,569$1.63MInsider
Luminus Management LLC1.12%1,016,720$1.23MInstitution
Shaun Oneil0.91%826,763$1.00MInsider
Michael Adam Gordon0.77%700,000$847.00kInsider
Vanguard Group Inc0.62%560,915$678.71kInstitution
Sargent Investment Group LLC0.60%541,500$655.22kInstitution
James L. Cox0.31%282,120$341.37kInsider
Geode Capital Management LLC0.31%279,504$338.20kInstitution

1 of 3

LUCD vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LUCD3.65%40.65%
PROF55.85%0.00%
RPID27.64%71.45%Net BuyingNet Selling
ELUT27.74%72.26%Net BuyingNet Buying
MGRM4.21%22.01%Net Buying

Lucid Diagnostics Stock Ownership FAQ

Who owns Lucid Diagnostics?

Lucid Diagnostics (NASDAQ: LUCD) is owned by 3.65% institutional shareholders, 40.65% Lucid Diagnostics insiders, and 55.70% retail investors. Pavmed Inc is the largest individual Lucid Diagnostics shareholder, owning 31.30M shares representing 34.49% of the company. Pavmed Inc's Lucid Diagnostics shares are currently valued at $37.56M.

If you're new to stock investing, here's how to buy Lucid Diagnostics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.